N. Anthony Coles - Sep 15, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
By: Beverly Dubs as attorney-in-fact For: N. Anthony Coles
Stock symbol
REGN
Transactions as of
Sep 15, 2021
Transactions value $
-$3,500,677
Form type
4
Date filed
9/17/2021, 04:01 PM
Previous filing
Aug 19, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $2.63M +6.91K +765.96% $380.95 7.81K Sep 15, 2021 Direct F1
transaction REGN Common Stock Options Exercise $1.74M +5.04K +64.51% $345.47 12.9K Sep 15, 2021 Direct F1
transaction REGN Common Stock Sale -$195K -300 -2.33% $651.36 12.6K Sep 15, 2021 Direct F1
transaction REGN Common Stock Sale -$719K -1.1K -8.77% $652.95 11.4K Sep 15, 2021 Direct F1, F2
transaction REGN Common Stock Sale -$523K -800 -6.99% $653.31 10.6K Sep 15, 2021 Direct F1, F3
transaction REGN Common Stock Sale -$264K -403 -3.78% $655.14 10.2K Sep 15, 2021 Direct F1, F4
transaction REGN Common Stock Sale -$919K -1.4K -13.66% $656.48 8.85K Sep 15, 2021 Direct F1, F5
transaction REGN Common Stock Sale -$549K -835 -9.44% $657.53 8.01K Sep 15, 2021 Direct F1
transaction REGN Common Stock Sale -$616K -935 -11.67% $658.65 7.08K Sep 15, 2021 Direct F1
transaction REGN Common Stock Sale -$198K -300 -4.24% $659.00 6.78K Sep 15, 2021 Direct F1
transaction REGN Common Stock Sale -$296K -448 -6.61% $660.78 6.33K Sep 15, 2021 Direct F1, F6
transaction REGN Common Stock Sale -$2.21M -3.34K -52.84% $661.56 2.98K Sep 15, 2021 Direct F1, F7
transaction REGN Common Stock Sale -$1.99K -3 -0.1% $662.55 2.98K Sep 15, 2021 Direct F1
transaction REGN Common Stock Sale -$601K -905 -30.36% $663.73 2.08K Sep 15, 2021 Direct F1, F8
transaction REGN Common Stock Sale -$780K -1.17K -56.55% $664.32 902 Sep 15, 2021 Direct F1, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -5.04K -100% $0.00* 0 Sep 15, 2021 Common Stock 5.04K $345.47 Direct F1, F10
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -6.91K -100% $0.00* 0 Sep 15, 2021 Common Stock 6.91K $380.95 Direct F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 1,101 shares of Company stock on September 15, 2021 at prices ranging from $652.48 to $652.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 800 shares of Company stock on September 15, 2021 at prices ranging from $653.11 to $653.52. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 403 shares of Company stock on September 15, 2021 at prices ranging from $655.14 to $655.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 1,400 shares of Company stock on September 15, 2021 at prices ranging from $656.18 to $656.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 448 shares of Company stock on September 15, 2021 at prices ranging from $660.29 to $660.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 3,344 shares of Company stock on September 15, 2021 at prices ranging from $661.02 to $661.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 905 shares of Company stock on September 15, 2021 at prices ranging from $663.15 to $663.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 1,174 shares of Company stock on September 15, 2021 at prices ranging from $664.00 to $664.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 15, 2021 at each separate price.
F10 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.